Open access · CC-BY
via OpenAlex
Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer
Soukaina Boutriq, Alicia González-González, Isaac J. Plaza-Andrades, Aurora Laborda-Illanes, Lidia Sánchez‐Alcoholado, Jesús Peralta-Linero, María Emilia Domínguez-Recio, Maria José Bermejo-Pérez, Rocío Lavado-Valenzuela, Emilio Alba, María Isabel Queipo‐Ortuño
Journal of Personalized Medicine · 2021 · ▲ 36 citations
Abstract
Endometrial cancer is one of the most common gynaecological malignancies worldwide. Histologically, two types of endometrial cancer with morphological and molecular differences and also therapeutic implications have been identified. Type I endometrial cancer has an endometrioid morphology and is estrogen-dependent, while Type II appears with non-endometrioid differentiation and follows an estrogen-unrelated pathway. Understanding the molecular biology and genetics of endometrial cancer is crucial for its prognosis and the development of novel therapies for its treatment. However, until now, scant attention has been paid to environmental components like the microbiome. Recently, due to emerging evidence that the uterus is not a sterile cavity, some studies have begun to investigate the composition of the endometrial microbiome and its role in endometrial cancer. In this review, we summarize the current state of this line of investigation, focusing on the relationship between gut and endometrial microbiome and inflammation, estrogen metabolism, and different endometrial cancer therapies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/jpm11070659
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Boutriq, S., González-González, A., Plaza-Andrades, I.J., Laborda-Illanes, A., Sánchez‐Alcoholado, L., Peralta-Linero, J., Domínguez-Recio, M.E., Bermejo-Pérez, M.J., Lavado-Valenzuela, R., Alba, E., & Queipo‐Ortuño, M.I. (2021). Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer. <em>Journal of Personalized Medicine</em>. https://doi.org/10.3390/jpm11070659
Vancouver
Boutriq S, González-González A, Plaza-Andrades IJ, Laborda-Illanes A, Sánchez‐Alcoholado L, Peralta-Linero J, et al. Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer. Journal of Personalized Medicine. 2021. doi:10.3390/jpm11070659.
BibTeX
@article{soukaina2021Gutand,
title = {Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer},
author = {Soukaina Boutriq and Alicia González-González and Isaac J. Plaza-Andrades and Aurora Laborda-Illanes and Lidia Sánchez‐Alcoholado and Jesús Peralta-Linero and María Emilia Domínguez-Recio and Maria José Bermejo-Pérez and Rocío Lavado-Valenzuela and Emilio Alba and María Isabel Queipo‐Ortuño},
journal = {Journal of Personalized Medicine},
year = {2021},
doi = {10.3390/jpm11070659},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Microbiology 2018
Open access · CC-BY
The Human Gut Microbiome – A Potential Controller of Wellness and Disease
World Journal of Cardiology 2020
Open access · CC-BY
Role of gut microbiota in cardiovascular diseases
World Journal of Gastroenterology 2016
Open access · CC-BY
Gut microbiota imbalance and colorectal cancer
Journal of Translational Medicine 2019
Open access · CC-BY
Smoking and microbiome in oral, airway, gut and some systemic diseases
World Journal of Diabetes 2019
Open access · CC-BY
Crosstalk between gut microbiota and antidiabetic drug action
Molecular Psychiatry 2016
Open access · CC-BY